Nuclear AR positivity was observed in 22.9% of 2398 urothelial carcinomas, including 399 (16.6%) with weak, 108 (4.5%) with moderate, and 41 (1.7%) with strong staining. This evidence concerns the gene AR and urothelial carcinoma.